Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Bupropion sustained release for treatment of tobacco dependence.

Hays JT, Ebbert JO.

Mayo Clin Proc. 2003 Aug;78(8):1020-4; quiz 1024. Review.

PMID:
12911050
2.
3.
4.

Review of bupropion for smoking cessation.

Richmond R, Zwar N.

Drug Alcohol Rev. 2003 Jun;22(2):203-20. Review.

PMID:
12850907
5.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
6.

Bupropion: a review of its use in the management of smoking cessation.

Holm KJ, Spencer CM.

Drugs. 2000 Apr;59(4):1007-24. Review.

PMID:
10804045
7.

Treatment of nicotine dependence with bupropion SR: review of its efficacy, safety and pharmacological profile.

Martinez-Raga J, Keaney F, Sutherland G, Perez-Galvez B, Strang J.

Addict Biol. 2003 Mar;8(1):13-21. Review.

PMID:
12745411
8.

Interventions for smoking cessation and reduction in individuals with schizophrenia.

Tsoi DT, Porwal M, Webster AC.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD007253. doi: 10.1002/14651858.CD007253.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;2:CD007253.

PMID:
20556777
9.

Bupropion sustained release and smoking cessation.

Goldstein MG.

J Clin Psychiatry. 1998;59 Suppl 4:66-72. Review.

PMID:
9554323
10.

Current pharmacological treatments for nicotine dependence.

George TP, O'Malley SS.

Trends Pharmacol Sci. 2004 Jan;25(1):42-8. Review.

PMID:
14723978
11.

Non-nicotine pharmacotherapy for smoking cessation.

Ferry LH.

Prim Care. 1999 Sep;26(3):653-69. Review.

PMID:
10436292
12.

Treatments for spit tobacco use: a quantitative systematic review.

Ebbert JO, Rowland LC, Montori VM, Vickers KS, Erwin PJ, Dale LC.

Addiction. 2003 May;98(5):569-83. Review.

PMID:
12751971
13.

New medications for nicotine dependence treatment.

Hurt RD.

Nicotine Tob Res. 1999;1 Suppl 2:S175-9; discussion S207-10. Review.

PMID:
11768177
14.

The safety of treatments for tobacco use disorder.

Little MA, Ebbert JO.

Expert Opin Drug Saf. 2016;15(3):333-41. doi: 10.1517/14740338.2016.1131817. Epub 2015 Dec 30. Review.

PMID:
26715118
15.

Bupropion sustained release. A therapeutic review of Zyban.

Zwar N, Richmond R.

Aust Fam Physician. 2002 May;31(5):443-7. Review.

PMID:
12043548
16.
17.

Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.

Dwoskin LP, Rauhut AS, King-Pospisil KA, Bardo MT.

CNS Drug Rev. 2006 Fall-Winter;12(3-4):178-207. Review.

18.

Does bupropion have advantages over other medical therapies in the cessation of smoking?

Tonstad S, Johnston JA.

Expert Opin Pharmacother. 2004 Apr;5(4):727-34. Review.

PMID:
15102559
19.

Bupropion sustained release: side effect profile.

Settle EC Jr.

J Clin Psychiatry. 1998;59 Suppl 4:32-6. Review.

PMID:
9554319
20.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928

Supplemental Content

Support Center